PFE logo

Pfizer Inc. (PFE)

Profile

Full Name

Pfizer Inc.

Ticker

NYSE: PFE

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

June 1, 1972

Indexes

S&P 500

Website

http://www.pfizer.com

Employees

81000

Key Details

Price

$25.65(-0.50%)

Market cap

$145.83B(Mega cap)

Last Dividend

$0.43

TTM Dividend yield

6.63%

Annual revenue

$63.63B(+6.84% YoY)

Annual EPS

$1.41(+281.08% YoY)

PE ratio

18.59

Next earnings date

Aug 5, 2025

Next ex-dividend date

Jul 25, 2025

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $25.65
    PFE price is $25.65

    30-Day Relative Volume

    0.91
    PFE 30-day relative volume is 0.91

    Price Performance

    Price Most recent change

    -0.5%
    PFE price was down -0.5% on Jul 11, 2025

    Price YTD change

    -3.32%
    PFE price is down -3.32% since January 1st

    Price 1-year change

    -10.5%
    PFE price is down -10.5% year-on-year

    Price 3-year change

    -51.5%
    PFE price is down -51.5% over the past 3 years

    Price Range

    Price All-time high

    $61.71
    PFE price is currently -58.43% below its historical high of $61.71

    Price 3-year low

    $20.92
    PFE price is currently +22.61% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $145.83B
    PFE market capitalization is $145.83 billion

    Market cap 3-year change

    -50.7%
    PFE market capitalization is down -50.7% over the past 3 years

    Market cap All-time high

    $343.79B
    PFE market capitalization is currently -57.58% below its historical high of $343.79 billion

    Market cap sector rank

    98.76%
    PFE market capitalization is higher than 98.76% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.33%
    PFE shares outstanding is up +0.33% year-on-year

    Shares Outstanding 3-Year Change

    +1.65%
    PFE shares outstanding is up +1.65% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.41
    PFE beta is 0.41

    200-day SMA

    $25.65
    PFE price is currently -0.01% below its 200-day simple moving average

    50-day SMA

    $23.89
    PFE price is currently +7.39% above its 50-day simple moving average

    RSI

    68.09
    PFE 14-day relative strength index is 68.09

    Volume

    0.91
    PFE 30-day relative volume is 0.91

    ATR

    $0.42
    PFE average true range is $0.42

    10-day Historical Volatility

    18.79%
    PFE 10-day historical volatility is 18.79%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.43
    PFE last dividend was $0.43 per share, with an ex-dividend date of May 9, 2025

    Next Dividend

    $0.43
    PFE has announced a dividend of $0.43 per share, with an ex-dividend date set for July 25, 2025

    Dividend per share

    Dividend per share

    $1.68
    PFE annual dividend per share is $1.68

    Dividend per share Sector Rank

    60%
    PFE annual dividend per share is higher than 60% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +2.44%
    PFE annual dividend per share is up +2.44% year-on-year

    Dividend per share 3-Year Change

    +7.69%
    PFE annual dividend per share is up +7.69% over the past 3 years

    Dividend yield

    Dividend yield

    6.55%
    PFE annual dividend yield is 6.55%

    Dividend yield Sector Rank

    90.48%
    PFE annual dividend yield is higher than 90.48% of companies in Healthcare sector

    Other

    Payout ratio

    118.44%
    PFE annual payout ratio is 118.44%

    Dividends paid

    $9.51B
    PFE annual dividends paid is $9.51 billion

    Free cash flow

    $9.84B
    PFE annual free cash flow is $9.84 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $63.63B
    PFE annual revenue is $63.63 billion

    Revenue Analysts estimate

    $62.44B
    PFE annual revenue is currently +1.90% higher than the consensus analysts' forecast

    Revenue 1-year change

    +6.84%
    PFE annual revenue is up +6.84% year-on-year

    Revenue Sector rank

    98.51%
    PFE annual revenue is higher than 98.51% of companies in Healthcare sector

    EPS

    EPS

    $1.41
    PFE annual earnings per share is $1.41

    EPS Analysts estimate

    $3.00
    PFE annual earnings per share is currently -52.96% lower than the consensus analysts' forecast

    EPS 1-year change

    +281.08%
    PFE annual earnings per share is up +281.08% year-on-year

    EPS Sector rank

    90.6%
    PFE annual earnings per share is higher than 90.6% of companies in Healthcare sector

    Profit

    Gross profit

    $45.78B
    PFE annual gross profit is $45.78 billion

    Gross margin

    71.94%
    PFE annual gross profit margin is 71.94%

    Operating profit

    $14.94B
    PFE annual operating income is $14.94 billion

    Operating margin

    23.48%
    PFE annual operating profit margin is 23.48%

    Net income

    $8.03B
    PFE annual net profit is $8.03 billion

    Net margin

    12.62%
    PFE annual net profit margin is 12.62%

    Expenses

    Total expenses

    $48.69B
    PFE annual total expenses is $48.69 billion

    Operating expenses

    $30.84B
    PFE annual total operating expenses is $30.84 billion

    Cost of goods sold

    $17.85B
    PFE annual cost of goods sold is $17.85 billion

    Selling, general & administrative expenses

    $14.73B
    PFE annual SGA is $14.73 billion

    Depreciation and amortization

    $7.01B
    PFE annual depreciation & amortization is $7.01 billion

    Interest expense

    $3.09B
    PFE annual interest expense is $3.09 billion

    Income tax

    -$28.00M
    PFE annual income tax is -$28.00 million

    EBIT & EBITDA

    EBIT

    $11.11B
    PFE annual earnings before interest & taxes is $11.11 billion

    EBITDA

    $16.40B
    PFE annual EBITDA is $16.40 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $213.40B
    PFE annual total assets is $213.40 billion

    Non current assets

    $163.04B
    PFE annual long term assets is $163.04 billion

    Current assets

    $50.36B
    PFE annual total current assets is $50.36 billion

    Cash and cash equivalents

    $1.04B
    PFE annual cash & cash equivalents is $1.04 billion

    Accounts receivable

    $11.46B
    PFE annual accounts receivable is $11.46 billion

    Inventory

    $10.85B
    PFE annual inventory is $10.85 billion

    Liabilities

    Total liabilities

    $124.90B
    PFE annual total liabilities is $124.90 billion

    Long term liabilities

    $81.90B
    PFE annual total long term liabilities is $81.90 billion

    Current liabilities

    $42.99B
    PFE annual total current liabilities is $42.99 billion

    Accounts payable

    $5.63B
    PFE annual accounts payable is $5.63 billion

    Debt

    Total debt

    $63.65B
    PFE annual total debt is $63.65 billion

    Total debt 1-year change

    -10.16%
    PFE annual total debt is down -10.16% year-on-year

    Long term debt

    $56.70B
    PFE annual long term debt is $56.70 billion

    Short term debt

    $6.95B
    PFE annual short term debt is $6.95 billion

    Equity & Capital

    Shareholders equity

    $88.20B
    PFE annual stockholders equity is $88.20 billion

    Book value

    $88.20B
    PFE annual book value is $88.20 billion

    Retained earnings

    $116.72B
    PFE annual retained earnings is $116.72 billion

    Working capital

    $7.36B
    PFE annual working capital is $7.36 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $12.74B
    PFE annual cash flow from operations is $12.74 billion

    Cash from operations 1-year change

    +46.48%
    PFE annual cash flow from operations is up +46.48% year-on-year

    Cash from investing

    $2.65B
    PFE annual cash flow from investing activities is $2.65 billion

    Cash from investing 1-year change

    +108.22%
    PFE annual cash flow from investing activities is up +108.22% year-on-year

    Cash from financing

    -$17.14B
    PFE annual cash flow from financing activities is -$17.14 billion

    Cash from financing 1-year change

    -165.76%
    PFE annual cash flow from financing activities is down -165.76% year-on-year

    CAPEX

    CAPEX

    $2.91B
    PFE annual capital expenditures is $2.91 billion

    CAPEX 1-year change

    -25.54%
    PFE annual capital expenditures is down -25.54% year-on-year

    Free Cash Flow

    Free cash flow

    $9.84B
    PFE annual free cash flow is $9.84 billion

    Free cash flow 1-year change

    +105.2%
    PFE annual free cash flow is up +105.2% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    71.94%
    PFE annual gross profit margin is 71.94%

    Operating margin

    23.48%
    PFE annual operating profit margin is 23.48%

    Net margin

    12.62%
    PFE annual net profit margin is 12.62%

    ROA & ROE

    ROA

    3.65%
    PFE annual return on assets is 3.65%

    ROE

    9.03%
    PFE annual return on equity is 9.03%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    18.59
    PFE price to earnings ratio is 18.59

    PE ratio Sector rank

    38.97%
    PFE price to earnings ratio is higher than 38.97% of companies in Healthcare sector

    PB Ratio

    PB ratio

    1.61
    PFE price to book ratio is 1.61

    PB ratio Sector rank

    50.29%
    PFE price to book ratio is higher than 50.29% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.33
    PFE price to sales ratio is 2.33

    PS ratio Sector rank

    42.63%
    PFE price to sales ratio is higher than 42.63% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $205.69B
    PFE enterprise value is $205.69 billion

    Enterprise value Sector rank

    99.17%
    PFE enterprise value is higher than 99.17% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    12.22
    PFE EV/EBITDA is 12.22

    EV/EBITDA Sector rank

    85.49%
    PFE EV/EBITDA is higher than 85.49% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.17
    PFE annual current ratio is 1.17

    Quick ratio

    0.92
    PFE annual quick ratio is 0.92

    Leverage

    Debt to equity

    0.72
    PFE annual debt to equity ratio is 0.72

    Interest coverage ratio

    3.60
    PFE annual interest coverage ratio is 3.60

    Risk & Stability

    Piotroski F-Score

    8
    PFE piotroski f-score is 8

    Altman Z-Score

    1.98
    PFE altman z-score is 1.98

    Analyst ratings

    Recent major analysts updates

    Apr 30, 25 UBS
    Neutral
    Apr 22, 25 Cantor Fitzgerald
    Neutral
    Apr 8, 25 UBS
    Neutral
    Apr 8, 25 Goldman Sachs
    Neutral
    Mar 18, 25 Guggenheim
    Buy
    Mar 12, 25 Guggenheim
    Buy
    Feb 10, 25 Guggenheim
    Buy
    Feb 5, 25 UBS
    Neutral
    Jan 28, 25 Citigroup
    Neutral
    Jan 8, 25 UBS
    Neutral

    Institutional Ownership

    Screeners with PFE included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    • What is the ticker symbol for Pfizer Inc.?
    • Does Pfizer Inc. pay dividends?
    • What sector is Pfizer Inc. in?
    • What industry is Pfizer Inc. in?
    • What country is Pfizer Inc. based in?
    • When did Pfizer Inc. go public?
    • Is Pfizer Inc. in the S&P 500?
    • Is Pfizer Inc. in the NASDAQ 100?
    • Is Pfizer Inc. in the Dow Jones?
    • When was Pfizer Inc.'s last earnings report?
    • When does Pfizer Inc. report earnings?

    What is the ticker symbol for Pfizer Inc.?

    The ticker symbol for Pfizer Inc. is NYSE:PFE

    Does Pfizer Inc. pay dividends?

    Yes, Pfizer Inc. pays dividends. The last payment was $0.43, with an ex-dividend date on May 9, 2025

    What sector is Pfizer Inc. in?

    Pfizer Inc. is in the Healthcare sector

    What industry is Pfizer Inc. in?

    Pfizer Inc. is in the Drug Manufacturers - General industry

    What country is Pfizer Inc. based in?

    Pfizer Inc. is headquartered in United States

    When did Pfizer Inc. go public?

    Pfizer Inc.'s initial public offering (IPO) was on June 1, 1972

    Is Pfizer Inc. in the S&P 500?

    Yes, Pfizer Inc. is included in the S&P 500 index

    Is Pfizer Inc. in the NASDAQ 100?

    No, Pfizer Inc. is not included in the NASDAQ 100 index

    Is Pfizer Inc. in the Dow Jones?

    No, Pfizer Inc. is not included in the Dow Jones index

    When was Pfizer Inc.'s last earnings report?

    Pfizer Inc.'s most recent earnings report was on April 29, 2025

    When does Pfizer Inc. report earnings?

    The next expected earnings date for Pfizer Inc. is August 5, 2025
    On this page